RTK-RAS pathway mutation is enriched in myeloid sarcoma

Blood Cancer J. 2018 May 23;8(5):43. doi: 10.1038/s41408-018-0083-6.

Authors

Mihong Choi¹, Yoon Kyung Jeon², Choong-Hyun Sun³, Hong-Seok Yun⁴, Junshik Hong¹, Dong-Yeop Shin¹, Inho Kim¹, Sung-Soo Yoon¹, Youngil Koh⁵

Affiliations

¹ Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
² Department of Pathology, Seoul National University Hospital, Seoul, Korea.
³ Development Group, Samsung SDS, Seoul, Korea.
⁴ Department of Bioinformatics, Seoul National University Hospital, Seoul, Korea.
⁵ Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. go01@snu.ac.kr.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Biomarkers, Tumor*
Child
Female
Humans
Male
Middle Aged
Mutation*
Receptor Protein-Tyrosine Kinases / metabolism*
Sarcoma, Myeloid / genetics*
Sarcoma, Myeloid / metabolism*
Signal Transduction*
Young Adult
ras Proteins / metabolism*

Substances

Biomarkers, Tumor
Receptor Protein-Tyrosine Kinases
ras Proteins